Description
An intermediate in the synthesis of ursodeoxycholic acid by intestinal bacteria in humans; increases the bile flow rate and the concentration of bile bicarbonate in rats via venous infusion at 1.2 µmol/min per 100 g body weight; levels are decreased in rat feces in a model of adenine-induced chronic renal failure; fecal levels are also reduced in patients with liver cirrhosis or hepatocellular carcinoma
Formal name: (3α,5β)-3-hydroxy-7-oxo-cholan-24-oic acid
Synonyms: 7-keto LCA|7-Oxolithocholic Acid|NSC 226118
Molecular weight: 390.6
CAS: 4651-67-6
Purity: ≥98%
Formulation: A crystalline solid